An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis

Figure 3

The estimated hazard ratio (HR) was summarized for the relationship between platelet-to-lymphocyte ratio and disease-free survival (a), between platelet-to-lymphocyte ratio and cancer-specific survival (b), and between platelet-to-lymphocyte ratio and recurrence-free survival (c).

(a)

(b)

(c)